Related references
Note: Only part of the references are listed.BX-795 inhibits neuroblastoma growth and enhances sensitivity towards chemotherapy
Rameswari Chilamakuri et al.
TRANSLATIONAL ONCOLOGY (2022)
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions
Karin Schmelz et al.
NATURE COMMUNICATIONS (2021)
Structural genomics approach to investigate deleterious impact of nsSNPs in conserved telomere maintenance component 1
Arunabh Choudhury et al.
SCIENTIFIC REPORTS (2021)
Genetic predisposition and chromosome instability in neuroblastoma
Gian Paolo Tonini et al.
CANCER AND METASTASIS REVIEWS (2020)
Monitoring Immune Responses in Neuroblastoma Patients during Therapy
Celina L. Szanto et al.
CANCERS (2020)
Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)
Ruth Ladenstein et al.
CANCERS (2020)
Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
S. L. George et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
Keith Holmes et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations
Samuel W. Brady et al.
NATURE COMMUNICATIONS (2020)
Genetic Alterations Detected by Targeted Next-generation Sequencing and Their Clinical Implications in Neuroblastoma
Kyung-Nam Koh et al.
ANTICANCER RESEARCH (2020)
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance
Susanne Fransson et al.
SCIENTIFIC REPORTS (2020)
Update on neuroblastoma
Erika A. Newman et al.
JOURNAL OF PEDIATRIC SURGERY (2019)
Targeting anaplastic lymphoma kinase in neuroblastoma
Ganesh Umapathy et al.
APMIS (2019)
Neuroblastoma - A Neural Crest Derived Embryonal Malignancy
John Inge Johnsen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma
Angela Bellini et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
Peter Utnes et al.
CANCER INFORMATICS (2019)
Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression
Fikret Rifatbegovic et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma
Nicholas Ho et al.
CELL CYCLE (2018)
Investigation of major genetic alterations in neuroblastoma
Regis Afonso Costa et al.
MOLECULAR BIOLOGY REPORTS (2018)
Patterns of genomic evolution in advanced melanoma
E. Birkeland et al.
NATURE COMMUNICATIONS (2018)
Systematic pan-cancer analysis of somatic allele frequency
Liam Spurr et al.
SCIENTIFIC REPORTS (2018)
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma
Thomas F. Eleveld et al.
CANCER RESEARCH (2018)
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2018)
A mechanistic classification of clinical phenotypes in neuroblastoma
Sandra Ackermann et al.
SCIENCE (2018)
Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma
Gary L. Gallia et al.
NATURE COMMUNICATIONS (2018)
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma
Holly L. Pacenta et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Personal Cancer Genome Reporter: variant interpretation report for precision oncology
Sigve Nakken et al.
BIOINFORMATICS (2018)
Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
Marilyn M. Li et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2017)
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2017)
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
Valentina Boeva et al.
NATURE GENETICS (2017)
Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo
Zhenghu Chen et al.
ONCOTARGET (2017)
Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
Yuanyuan Li et al.
ONCOTARGET (2017)
OncoScore: a novel, Internetbased tool to assess the oncogenic potential of genes
Piazza Rocco et al.
SCIENTIFIC REPORTS (2017)
Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
Wan-Ling Ho et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia
Koichi Oshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Genome-wide association study identifies multiple susceptibility loci for craniofacial microsomia
Yong-Biao Zhang et al.
NATURE COMMUNICATIONS (2016)
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
Vito Alessandro Lasorsa et al.
ONCOTARGET (2016)
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M. Padovan-Merhar et al.
PLOS GENETICS (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Linda J. Valentijn et al.
NATURE GENETICS (2015)
The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
Gaurav Kumar Pandey et al.
CANCER CELL (2014)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
MYCN-Dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival
Valeria Solari et al.
CANCER RESEARCH (2014)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Odorant receptor genes are expressed in olfactory neuroblastoma
D. C. Gonzalez-Kristeller et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Assessment of computational methods for predicting the effects of missense mutations in human cancers
Florian Gnad et al.
BMC GENOMICS (2013)
Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs
Christopher T. Saunders et al.
BIOINFORMATICS (2012)
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
G. Schleiermacher et al.
BRITISH JOURNAL OF CANCER (2012)
Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma
Marcella Devoto et al.
HUMAN HEREDITY (2011)
Predicting the functional impact of protein mutations: application to cancer genomics
Boris Reva et al.
NUCLEIC ACIDS RESEARCH (2011)
p53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Lindi Chen et al.
CANCER RESEARCH (2010)
Neuroblastoma: Therapeutic strategies for a clinical enigma
Shakeel Modak et al.
CANCER TREATMENT REVIEWS (2010)
Targeting RET Receptor Tyrosine Kinase Activation in Cancer
John E. Phay et al.
CLINICAL CANCER RESEARCH (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gene ontology analysis for RNA-seq: accounting for selection bias
Matthew D. Young et al.
GENOME BIOLOGY (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
Tom Monclair et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The first 30 years of p53: growing ever more complex
Arnold J. Levine et al.
NATURE REVIEWS CANCER (2009)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
UTRN on chromosome 6q24 is mutated in multiple tumors
Y. Li et al.
ONCOGENE (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma
M Aoyama et al.
CANCER RESEARCH (2005)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Association of ABCA2 expression with determinants of Alzheimer's disease
ZJJ Chen et al.
FASEB JOURNAL (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
The p53 pathway and its inactivation in neuroblastoma
DA Tweddle et al.
CANCER LETTERS (2003)
Screening of infants and mortality due to neuroblastoma
WG Woods et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
